Brief: Alkem Laboratories To Acquire 100% Stake In Adroit Biomed
07/02/2025 09:39
Feb 7 (Reuters) - Alkem Laboratories Ltd ALKE.NS :
* TO ACQUIRE 100% STAKE IN ADROIT BIOMED
* DEAL FOR 1.4 BILLION RUPEES
Source text: ID:nNSE7hrctF
Further company coverage: ALKE.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Alkem Laboratories
See all newsBrief: Alkem Labs Approved Initiation Of Forensic Audit In Connection With Recent Incident Involving Alleged Misappropriation Of Funds By A Former Employee
Brief: Alkem Labs Launches Neuceno (Cenobamate) For Treatment Of Partial-Onset Seizures In Adult Patients
Brief: Alkem Labs Launches Renocia Exo, Ginsenoside Exosome-Based Hair Growth Serum
Brief: Alkem Labs Board Approves Investment Of Up To 750 Million Rupees For New Block At Baddi Manufacturing Facility
Brief: Alkem Laboratories Q1 Consol Revenue From Operations 37.4 Billion Rupees